BAY K 8644 acts as a dihydropyridine calcium channel agonist, stimulating calcium uptake in a voltage-dependent manner.
This is the authors' abstract. We don't add key points for this paper.
Methyl 1,4-dihydro-2, 6-dimethyl-3-nitro-4-(2-trifluoromethylphenyl)-pyridine-5-carboxylate (BAY K 8644), an analog of dihydropyridine calcium channel antagonists, stimulated 45Ca uptake into PC12 pheochromocytoma cells. Half-maximal stimulation occurred at 80 nM BAY K 8644. Enhancement of uptake was inhibited by cationic and organic calcium channel blockers, but not by tetrodotoxin, which is consistent with an effect on voltage-dependent calcium channels. Stimulation of 45Ca uptake by BAY K 8644 occurred only at elevated concentrations of extracellular K+, suggesting that BAY K 8644 may interact with calcium channels in the open (activated) state.
Answers are grounded in this paper and cite their sources.
No clinical implications from this cell study; leaves open translation of dihydropyridine calcium agonists to cardiovascular models.
No takes yet. Share an insight, caveat, or question.
Greenberg et al. (1985) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: